Pages that link to "Q39713485"
The following pages link to Ovarian cancer ascites protects from TRAIL-induced cell death through alphavbeta5 integrin-mediated focal adhesion kinase and Akt activation (Q39713485):
Displaying 50 items.
- Ascites modulates cancer cell behavior, contributing to tumor heterogeneity in ovarian cancer (Q26746203) (← links)
- Cell-cell and cell-matrix dynamics in intraperitoneal cancer metastasis (Q26851836) (← links)
- FAK in cancer: mechanistic findings and clinical applications (Q27026533) (← links)
- Alterations in ovarian cancer cell adhesion drive taxol resistance by increasing microtubule dynamics in a FAK-dependent manner (Q30640795) (← links)
- Role of malignant ascites on human mesothelial cells and their gene expression profiles (Q33559857) (← links)
- Prognostic significance of IL-6 and IL-8 ascites levels in ovarian cancer patients (Q33914512) (← links)
- FAK Inhibition disrupts a β5 integrin signaling axis controlling anchorage-independent ovarian carcinoma growth (Q34021043) (← links)
- The wedelolactone derivative inhibits estrogen receptor-mediated breast, endometrial, and ovarian cancer cells growth (Q34147026) (← links)
- The inhibition of Bid expression by Akt leads to resistance to TRAIL-induced apoptosis in ovarian cancer cells (Q34428852) (← links)
- Cell population-specific expression analysis of human cerebellum (Q34474749) (← links)
- Acellular fraction of ovarian cancer ascites induce apoptosis by activating JNK and inducing BRCA1, Fas and FasL expression in ovarian cancer cells (Q34781244) (← links)
- Myxoma virus-mediated oncolysis of ascites-derived human ovarian cancer cells and spheroids is impacted by differential AKT activity (Q35216344) (← links)
- Targeted ovarian cancer treatment: the TRAILs of resistance. (Q35609438) (← links)
- Inflammation-regulating factors in ascites as predictive biomarkers of drug resistance and progression-free survival in serous epithelial ovarian cancers (Q35677625) (← links)
- Ascites Increases Expression/Function of Multidrug Resistance Proteins in Ovarian Cancer Cells. (Q35684285) (← links)
- Vitronectin inhibits neutrophil apoptosis through activation of integrin-associated signaling pathways (Q36049729) (← links)
- Profiling of cytokines in human epithelial ovarian cancer ascites. (Q36206483) (← links)
- Canstatin inhibits hypoxia-induced apoptosis through activation of integrin/focal adhesion kinase/Akt signaling pathway in H9c2 cardiomyoblasts (Q36290081) (← links)
- Meeting the challenge of ascites in ovarian cancer: new avenues for therapy and research. (Q36358324) (← links)
- Osteoprotegerin (OPG) protects ovarian cancer cells from TRAIL-induced apoptosis but does not contribute to malignant ascites-mediated attenuation of TRAIL-induced apoptosis (Q36427134) (← links)
- Ovarian cancer ascites increase Mcl-1 expression in tumor cells through ERK1/2-Elk-1 signaling to attenuate TRAIL-induced apoptosis (Q36478459) (← links)
- Moving beyond VEGF for anti-angiogenesis strategies in gynecologic cancer (Q37086837) (← links)
- CCL18 from ascites promotes ovarian cancer cell migration through proline-rich tyrosine kinase 2 signaling (Q37244183) (← links)
- Osteoprotegerin (OPG) activates integrin, focal adhesion kinase (FAK), and Akt signaling in ovarian cancer cells to attenuate TRAIL-induced apoptosis (Q37418199) (← links)
- Malignant ascites enhances migratory and invasive properties of ovarian cancer cells with membrane bound IL-6R in vitro (Q37696280) (← links)
- Malignant pleural effusion: tumor-host interactions unleashed (Q38015001) (← links)
- Focal adhesion kinase inhibitor PF573228 and death receptor 5 agonist lexatumumab synergistically induce apoptosis in pancreatic carcinoma (Q38705400) (← links)
- High expression of crystallin αB represents an independent molecular marker for unfavourable ovarian cancer patient outcome and impairs TRAIL- and cisplatin-induced apoptosis in human ovarian cancer cells. (Q39229600) (← links)
- Olfactomedin III expression contributes to anoikis-resistance in clonal variants of a human lung squamous carcinoma cell line. (Q39405715) (← links)
- Ascites promotes cell migration through the repression of miR-125b in ovarian cancer (Q41612575) (← links)
- Integrin Activation Contributes to Lower Cisplatin Sensitivity in MV3 Melanoma Cells by Inducing the Wnt Signalling Pathway (Q41670861) (← links)
- Integrin signaling in cancer cell survival and chemoresistance (Q42198719) (← links)
- Collagen triple helix repeat containing 1 (CTHRC1) activates Integrin β3/FAK signaling and promotes metastasis in ovarian cancer (Q42375241) (← links)
- Vitronectin (Vn) glycosylation patterned by lectin affinity assays-A potent glycoproteomic tool to discriminate plasma Vn from cancer ascites Vn. (Q47367919) (← links)
- PTK2-mediated degradation of ATG3 impedes cancer cells susceptible to DNA damage treatment (Q48864865) (← links)
- Malignant pleural fluid from mesothelioma has potent biological activities. (Q50197656) (← links)
- Ovarian cancer ascites enhance the migration of patient-derived peritoneal mesothelial cells via cMet pathway through HGF-dependent and -independent mechanisms. (Q53668906) (← links)
- 2017 Update on Ovarian Cancer Peritoneal Carcinomatosis Multimodal-Treatment Considerations. (Q55041329) (← links)
- DAXX promotes ovarian cancer ascites cell proliferation and migration by activating the ERK signaling pathway (Q58598951) (← links)
- Exome-wide analysis identifies three low-frequency missense variants associated with pancreatic cancer risk in Chinese populations (Q58751735) (← links)
- Integrin Signaling as a Cancer Drug Target (Q58992474) (← links)
- Mechanisms of Matrix-Induced Chemoresistance of Breast Cancer Cells-Deciphering Novel Potential Targets for a Cell Sensitization (Q60912359) (← links)
- Therapeutic Implication of SOCS1 Modulation in the Treatment of Autoimmunity and Cancer (Q64054927) (← links)
- Ascites from ovarian cancer patients stimulates MUC16 mucin expression and secretion in human peritoneal mesothelial cells through an Akt-dependent pathway (Q64077659) (← links)
- Ascites IL-10 Promotes Ovarian Cancer Cell Migration. (Q64938549) (← links)
- Ascites-induced shift along epithelial-mesenchymal spectrum in ovarian cancer cells: enhancement of their invasive behavior partly dependant on αv integrins (Q88114021) (← links)
- Malignant ascites-derived organoid (MADO) cultures for gastric cancer in vitro modelling and drug screening (Q90622487) (← links)
- Metabolic Factors Contribute to T-cell Inhibition in the Ovarian Cancer Ascites (Q90623679) (← links)
- Integrin α5 promotes migration and cisplatin resistance in esophageal squamous cell carcinoma cells (Q92481982) (← links)
- A combined FAK, c-MET, and MST1R three-protein panel risk-stratifies colorectal cancer patients (Q98187269) (← links)